• Thumbnail for Rituximab
    Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of...
    47 KB (4,277 words) - 19:46, 30 March 2024
  • Thumbnail for Pemphigus vulgaris
    antibodies such as rituximab, which are increasingly being used as first-line treatment. In summer 2018, the FDA granted full approval to rituximab for this application...
    17 KB (1,941 words) - 14:31, 22 March 2024
  • Thumbnail for Marginal zone lymphoma
    immunotherapy (i.e. rituximab, or a combination (e.g. chlorambucil + rituximab or fludarabine + rituximab or bendamustine + rituximab) immunotherapy plus...
    116 KB (14,599 words) - 20:09, 24 January 2024
  • Thumbnail for Follicular lymphoma
    of t-FL (e.g. the addition to standard chemotherapy of agents such as rituximab) have improved overall survival times. These newer regimens may also delay...
    67 KB (7,967 words) - 19:22, 29 April 2024
  • methotrexate for moderate to severe rheumatoid arthritis. The biologic agent rituximab (anti-B cell therapy) is now licensed for use in refractory rheumatoid...
    15 KB (1,474 words) - 08:38, 1 May 2024
  • Thumbnail for Bullous pemphigoid
    patients who cannot use corticosteroids. The anti-CD20 monoclonal antibody rituximab has been found to be effective in treating some otherwise refractory cases...
    13 KB (1,283 words) - 01:12, 8 November 2023
  • corticosteroids. Sometimes the chimeric anti-CD20 monoclonal antibody, rituximab, is added to this treatment regimen to form the R-CHOP regimen. R-miniCHOP...
    10 KB (948 words) - 12:38, 26 March 2024
  • Thumbnail for Venetoclax
    multicenter, open-label trial of venetoclax with rituximab (VEN+R) versus bendamustine with rituximab (B+R) in 389 participants with CLL who had received...
    26 KB (2,389 words) - 05:48, 7 April 2024
  • Thumbnail for Granulomatosis with polyangiitis
    as rituximab or cyclophosphamide and high-dose corticosteroids to control the symptoms of the disease and azathioprine, methotrexate, or rituximab to...
    30 KB (3,162 words) - 05:26, 13 March 2024
  • anti-CD20 monoclonal antibody rituximab (Rituxan, Mabthera) it is called R-DHAP or DHAP-R. [R]-DHAP regimen consists of: Rituximab, a monoclonal antibody, directed...
    2 KB (125 words) - 16:04, 9 November 2021
  • combined today with rituximab. This regimen is then called ICE-R or R-ICE or RICE. [R]-ICE regimen consists of:[citation needed] Rituximab - an anti-CD20 monoclonal...
    3 KB (183 words) - 16:45, 9 November 2021
  • Thumbnail for Ibrutinib
    Additionally, ibrutinib down-modulates the expression of CD20 (target of rituximab/ofatumumab) by targeting the CXCR4/SDF1 axis. Together, these data are...
    29 KB (2,582 words) - 04:23, 2 April 2024
  • Thumbnail for Bendamustine
    (MCL), with or without prior rituximab-containing chemoimmunotherapy treatment, is bendamustine with mitoxantrone and rituximab. In Germany in 2012 it has...
    14 KB (1,239 words) - 21:21, 2 March 2024
  • follitropin alfa, infliximab, insulin aspart, insulin glargine, pegfilgrastim, rituximab, teriparatide, and trastuzumab. A research article about "Maximizing the...
    95 KB (6,479 words) - 21:14, 31 March 2024
  • Thumbnail for Mantle cell lymphoma
    bendamustine with rituximab. Second line treatment may include fludarabine, combined with cyclophosphamide and/or mitoxantrone, usually with rituximab. Cladribine...
    41 KB (4,549 words) - 08:59, 25 January 2024
  • Mayerhoefer ME, Lukas J, Zielinski CC, Müllauer L, Raderer M (2014). "Rituximab plus bendamustine is active in pretreated patients with extragastric marginal...
    22 KB (562 words) - 06:39, 30 November 2023
  • Thumbnail for Thrombotic thrombocytopenic purpura
    90% to less than 20%. Immunosuppressants, such as glucocorticoids, and rituximab may also be used. Platelet transfusions are generally not recommended...
    41 KB (3,902 words) - 01:19, 29 February 2024
  • Thumbnail for MALT lymphoma
    disseminated disease at presentation or lack of response to local treatment. Rituximab, the anti-CD20 chimeric antibody, is a key component of therapy. Responses...
    19 KB (2,133 words) - 09:43, 24 January 2024
  • Thumbnail for Hodgkin lymphoma
    often treated differently from classic Hodgkin lymphoma, including using rituximab in combination with AVBD chemotherapy, though individual cases vary and...
    87 KB (8,577 words) - 08:59, 21 April 2024
  • It is often combined with rituximab. In this case it is called R-EPOCH or EPOCH-R.The R-EPOCH regimen consists of: Rituximab: an anti-CD20 monoclonal antibody...
    6 KB (684 words) - 09:38, 30 September 2022
  • promise in this technique treating anti-MAG neuropathies.[citation needed] Rituximab is considered to be one of the most promising drugs in the treatment of...
    17 KB (2,039 words) - 18:54, 12 November 2023
  • Thumbnail for Diffuse large B-cell lymphoma
    monoclonal antibody drug that targets the disease's cancerous B-cells, usually rituximab. Through these treatments, more than half of all patients with DLBCL can...
    69 KB (8,143 words) - 18:36, 22 January 2024
  • CoQ10. A potential use for rituximab was identified by two Norwegian doctors who were treating people who had cancer with rituximab; two people also had chronic...
    54 KB (6,022 words) - 10:57, 4 May 2024
  • Thumbnail for Oncology
    expansion in the use of monoclonal antibody treatments, notably for lymphoma (Rituximab) and breast cancer (Trastuzumab). Vaccines and other immunotherapies are...
    24 KB (2,589 words) - 12:32, 13 January 2024
  • Thumbnail for Cancer immunotherapy
    destruction by the immune system. Examples of such antibodies include rituximab (targeting CD-20), trastuzumab (targeting HER-2), and cetuximab (targeting...
    90 KB (9,943 words) - 14:26, 10 May 2024
  • follicular lymphoma as a second line treatment to a regimen containing rituximab. It was not tested in pregnant women. Obinutuzumab has two black box warnings:...
    17 KB (1,467 words) - 09:10, 9 April 2024
  • Thumbnail for Myasthenia gravis
    treatment. Other immune suppressing medications may also be used including rituximab or azathioprine. If the myasthenia is serious (myasthenic crisis), plasmapheresis...
    58 KB (5,998 words) - 00:49, 28 April 2024
  • Ocrelizumab binds to an epitope that overlaps with the epitope to which rituximab binds. It was approved by the US Food and Drug Administration (FDA) in...
    17 KB (1,666 words) - 03:17, 20 April 2024
  • Thumbnail for Monoclonal antibody
    Ipilimumab Nivolumab Ofatumumab Panitumumab Pembrolizumab Ranibizumab Rituximab Trastuzumab Monoclonal antibodies used for autoimmune diseases include...
    47 KB (4,794 words) - 19:52, 5 May 2024
  • Thumbnail for Immune thrombocytopenic purpura
    T cells can be influenced by medications that target B cells, such as rituximab. The diagnosis of ITP is a process of exclusion. First, it has to be determined...
    48 KB (5,332 words) - 04:41, 13 March 2024